Proposed Data Collections Submitted for Public Comment and Recommendations, 62473-62474 [E6-17853]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
the Antidiscrimination Laws and
Whistleblower Protection Laws or, if
applicable, the administrative or
negotiated grievance procedures in
order to pursue any legal remedy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disciplinary Actions
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Biosurveillance
Workgroup Meeting
Under the existing laws, each agency
retains the right, where appropriate, to
discipline a Federal employee for
conduct that is inconsistent with
Federal Antidiscrimination and
Whistleblower Protection Laws, up to
and including removal. If OSC has
initiated an investigation under 5 U.S.C.
1214, however, according to 5 U.S.C.
1214(f), agencies must seek approval
from the Special Counsel to discipline
employees for, among other activities,
engaging in prohibited retaliation.
Nothing in the No FEAR Act alters
existing laws or permits an agency to
take unfounded disciplinary action
against a Federal employee or to violate
the procedural rights of a Federal
employee who has been accused of
discrimination.
SUMMARY: This notice announces the
eleventh meeting of the American
Health Information Community
Biosurveillance Workgroup in
accordance with the Federal Advisory
Committee Act (Pub. L. 92–463, 5
U.S.C., App.)
DATES: November 9, 2006, from 1 p.m.
to 5 p.m.
ADDRESSES: Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090 (please
bring photo ID for entry to a Federal
building).
Additional Information
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090 (please
bring photo ID for entry to a Federal
building).
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
cps_main.html.
SUPPLEMENTARY INFORMATION:
Workgroup members will continue to
discuss the issues surrounding identity
proofing and user authentication in
preparation for the December 12th
American Health Information
Community meeting.
The meeting will be available via Web
cast at https://www.hhs.gov/healthit/
ahic/cps_instruct.html.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
For further information regarding the
No FEAR Act regulations, refer to 5 CFR
part 724, as well as the appropriate
offices within your agency (e.g., EEO/
civil rights office, human resources
office or legal office). At the Office of
Government Ethics, the Equal
Employment Opportunity Officer is
Grace A. Clark and she may be
contacted by telephone at 202–482–
9225, TDD at 202–482–9293, E-mail at
gaclark@oge.gov or by FAX at 202–482–
9238.
Additional information regarding
Federal antidiscrimination,
whistleblower protection and retaliation
laws can be found at the EEOC Web
site—https://www.eeoc.gov and the OSC
Web site—https://www.osc.gov.
Existing Rights Unchanged
Pursuant to section 205 of the No
FEAR Act, neither the Act nor this
notice creates, expands or reduces any
rights otherwise available to any
employee, former employee or applicant
under the laws of the United States,
including the provisions of law
specified in 5 U.S.C. 2302(d).
mstockstill on PROD1PC61 with NOTICES
62473
Approved: October 17, 2006.
Robert I. Cusick,
Director, Office of Government Ethics.
[FR Doc. E6–17847 Filed 10–24–06; 8:45 am]
BILLING CODE 6345–02–P
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
ACTION:
Announcement of meeting.
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
bio_main.html.
The
Workgroup will continue reviewing and
discussing the ‘‘Biosurveillance Priority
Area Matrix,’’ and further review
information on a Minimum Data Set
from the Data Steering Group.
The meeting will be available via Web
cast at https://www.hhs.gov/healthit/
ahic/bio_instruct.html.
Dated: October 12, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–8858 Filed 10–24–06; 8:45 am]
BILLING CODE 4150–24–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Confidentiality, Privacy
and Security Workgroup Meeting
ACTION:
Announcement of meeting.
SUMMARY: This notice announces the
fifth meeting of the American Health
Information Community Confidentiality,
Privacy and Security Workgroup in
accordance with the Federal Advisory
Committee Act (Pub. L. 92–463, 5
U.S.C., App.)
DATES: November 13, 2006, from 1 p.m.
to 4 p.m.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Dated: October 17, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–8859 Filed 10–24–06; 8:45 am]
BILLING CODE 4150–24–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–0638]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
E:\FR\FM\25OCN1.SGM
25OCN1
62474
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Follow-up Study of Chronic Fatigue
Syndrome in Georgia—Reinstatement–
0920–0638—Coordinating Center for
Infectious Diseases (CCID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is planning a follow-up study of
Chronic Fatigue Syndrome (CFS) in
metropolitan, urban and rural
communities in Georgia. This is in
response to Congressional
recommendations that the Centers for
Disease Control and Prevention (CDC)
sustain efforts to identify biomarkers for
CFS, educate health care providers
national and pilot regional provider
education programs designed to teach
health care providers how to evaluate,
diagnose and manage patients with CFS.
The proposed study builds on
information from the Georgia survey
with the objective of collecting clinical
information that will help in the
treatment of CFS and will help to
interpret results obtained from testing
biologic specimens (i.e., identify
biomarkers of CFS). This follow-up
study begins with a detailed telephone
interview of persons who participated
in the earlier survey and volunteered to
be contacted again. The interview is
similar (with minor modifications) to
the original interview and is intended to
obtain additional data on participant
health status during the last twelvemonth period. Eligible subjects with
CFS, other fatiguing illnesses, and well
controls will be asked to participate in
clinical evaluations.
about the diagnosis and treatment of
CFS, and better inform the public about
it to aid early detection and improve
patient care.
In 2004, OMB approved the
information collection, Survey of
Chronic Fatigue Syndrome and Chronic
Unwellness in Georgia, under OMB
Number 0920–0638. This study
provided baseline information on CFS
and other unexplained fatiguing illness
in metropolitan, urban, and rural
regions in Georgia. Data from the
proposed Follow-up Study of Chronic
Fatigue Syndrome in Georgia will be
used to describe the clinical course of
CFS and evaluate behavioral and
biochemical factors associated with
outcome. This follow-up study will also
determine access to and utilization of
health care by persons with CFS and
measure direct and indirect economic
burden due to the illness. As part of a
control strategy, the information from
this follow-up study will be used in
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Number
responses
per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Telephone interview .........................................................................................
Clinical Evaluation ...........................................................................................
2,870
338
1
1
30/60
450/60
1,435
2,535
Total ..........................................................................................................
........................
........................
........................
3,970
Dated: October 19, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–17853 Filed 10–24–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC61 with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 50065, dated
August 14, 2006), is amended to reflect
the establishment of the Healthy Aging
Program within the Division of Adult
and Community Health, National Center
for Chronic Disease Prevention and
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
Health Promotion, Coordinating Center
for Health Promotion, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as follow:
After the Office of the Director
(CUCE1), Division of Adult and
Community Health (CUCE) National
Center for Chronic Disease Prevention
and Health Promotion (CUC), insert the
following:
Healthy Aging Program (CUCE2). (1)
Serves as an active link between public
health and aging services networks to
provide leadership in health promotion
and disease prevention for older adults;
(2) provides scientific expertise and
rigor to health promoting strategies and
interventions through the use of data
and research; (3) disseminates
prevention messages, programs, and
policies; (4) contributes to the capacity
of systems and organizations to improve
the health of older adults; (5)
administers grants, cooperative
agreements, contracts, and other
procurement requests to implement
evidence-based health promotion
interventions and disseminates health
aging messages; (6) promotes expanding
prevention research for older adults by
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
supporting the Prevention Research
Centers Healthy Aging Research
Network (PRC–HAN); (7) administers
data into action through the
development of The State of Aging and
Health in America report series; (8)
collaborates with aging organizations to
expand the reach to professionals, the
public, and the media through the
development and evaluation of webbased health promotion modules and
media backgrounders on various older
adult health topics; and (9) directs and
disseminates the national public health
and action plan for brain health as part
of the Alzheimer’s disease segment of
the Healthy Aging Program.
Delete in its entirety the title and
functional statement for the Healthcare
and Aging Studies Branch (CUCEC), and
insert the following: Arthritis, Epilepsy
and Quality of Life Branch (CUCEC). (1)
Directs and supports activities that
increase the overall quality of life for
people affected by arthritis; (2) directs
and supports activities that improve
medical care, improve communication
and combat stigma, enhance selfmanagement, support surveillance and
prevention research, and increase public
awareness and knowledge about
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 71, Number 206 (Wednesday, October 25, 2006)]
[Notices]
[Pages 62473-62474]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17853]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-0638]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the
[[Page 62474]]
burden of the collection of information on respondents, including
through the use of automated collection techniques or other forms of
information technology. Written comments should be received within 60
days of this notice.
Proposed Project
Follow-up Study of Chronic Fatigue Syndrome in Georgia--
Reinstatement-0920-0638--Coordinating Center for Infectious Diseases
(CCID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is planning a follow-up study of Chronic Fatigue Syndrome (CFS)
in metropolitan, urban and rural communities in Georgia. This is in
response to Congressional recommendations that the Centers for Disease
Control and Prevention (CDC) sustain efforts to identify biomarkers for
CFS, educate health care providers about the diagnosis and treatment of
CFS, and better inform the public about it to aid early detection and
improve patient care.
In 2004, OMB approved the information collection, Survey of Chronic
Fatigue Syndrome and Chronic Unwellness in Georgia, under OMB Number
0920-0638. This study provided baseline information on CFS and other
unexplained fatiguing illness in metropolitan, urban, and rural regions
in Georgia. Data from the proposed Follow-up Study of Chronic Fatigue
Syndrome in Georgia will be used to describe the clinical course of CFS
and evaluate behavioral and biochemical factors associated with
outcome. This follow-up study will also determine access to and
utilization of health care by persons with CFS and measure direct and
indirect economic burden due to the illness. As part of a control
strategy, the information from this follow-up study will be used in
national and pilot regional provider education programs designed to
teach health care providers how to evaluate, diagnose and manage
patients with CFS.
The proposed study builds on information from the Georgia survey
with the objective of collecting clinical information that will help in
the treatment of CFS and will help to interpret results obtained from
testing biologic specimens (i.e., identify biomarkers of CFS). This
follow-up study begins with a detailed telephone interview of persons
who participated in the earlier survey and volunteered to be contacted
again. The interview is similar (with minor modifications) to the
original interview and is intended to obtain additional data on
participant health status during the last twelve-month period. Eligible
subjects with CFS, other fatiguing illnesses, and well controls will be
asked to participate in clinical evaluations.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Respondents respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Telephone interview............................. 2,870 1 30/60 1,435
Clinical Evaluation............................. 338 1 450/60 2,535
---------------------------------------------------------------
Total....................................... .............. .............. .............. 3,970
----------------------------------------------------------------------------------------------------------------
Dated: October 19, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-17853 Filed 10-24-06; 8:45 am]
BILLING CODE 4163-18-P
